A cell culture system for the study of amyloid pathogenesis: Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 123-133

  Kluve Beckerman, Barbara ^a   Liepnieks, Juris J ^a   Wang, Lishan ^a   Benson, Merrill D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; RECOMBINANT PROTEIN;

ACUTE PHASE RESPONSE; AMYLOIDOSIS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL STRUCTURE; CULTURE MEDIUM; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PH; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; STAINING;

EID: 0033021099     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65107-3     Document Type: Article

References (55)

1. Benditt EP, Eriksen N, Hermodsen MA, Ericsson LH: The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett 1971, 19:169-173
2. Levin M, Franklin EC, Frangione B, Pras M: The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 1972, 51:2773-2776
3. Husebekk A, Skogen B, Husby G, Marhaug G: Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985, 21:283-287
4. Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD: Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int J Exp Clin Invest 1994, 1:119-137
5. Benson MD, Kleiner E: Synthesis and secretion of serum amyloid A (SAA) by hepatocytes in mice treated with casein. J Immunol 1980, 124:495-499
6. Hoffman JS, Benditt EP: Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982, 257:10518-10522
7. Benditt EP, Eriksen N: Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977, 74:4025-4028
8. McAdam KPW, Elin RJ, Sipe JD, Wolff SM: Changes in human serum amyloid A and C-reactive protein following etiocholanlolone-induced inflammation. J Clin Invest 1978, 61:390-394
9. Lowell CA, Stearman RS, Morrow JF: Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986, 261 8453-8461
10. Sipe JD, Rokita H. de Beer FC: Cytokine regulation of the mouse SAA gene family. Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. Edited by A Mackiewicz, I Kushner, H Baumann. Boca Raton, FL, CRC Press, 1993, pp 511-526
11. Cooper JH: Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Lab Invest 1974, 31:232-238
12. Glenner GG: Amyloid deposits and amyloidois. The β-fibrilloses. N Engl J Med 1980, 302:1283-1292, 1333-1343
13. Husby G: Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985, 3:173-180
14. Benson MD: Amyloidosis. The Metabolic and Molecular Bases of Inherited Disease, ed 7. Edited by CR Scriver, AL Beaudet, WS Sly, D Valle. New York, McGraw-Hill, 1995, pp 4159-4191
15. Skinner M, Shirahama JT, Benson MD, Cohen AS: Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977, 36:420-427
16. Kisilevsky R, Benson MD, Axelrad MA, Boudreau L: The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition. Lab Invest 1979, 41:206-210
17. Ali-Khan Z, Li W, Chan SL: Animal model for the pathogenesis of reactive amyloidosis. Parasitol Today 1996, 12:297-302
18. 1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986, 3:387-407
19. Kisilevsky R, Narindrasorasak S, Tape C, Tan R, Boudreau L: During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre-or post-fibrillogenic event? Amyloid Int J Exp Clin Invest 1994, 1:174-183
20. Yamamoto K-I, Migita S: Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc Natl Acad Sci USA 1985, 82:2915-2919
21. Dwulet FE, Wallace DK, Benson MD: Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 1988, 27:1677-1682
22. Sletten K, Husebekk A, Husby G: The primary structure of equine serum amyloid A (SAA) protein. Scand J Immunol 1989, 30:117-122
23. Marhaug G, Husby G, Dowton SB: Mink serum amyloid A protein. Expression and primary sequence based on cDNA sequences. J Biol Chem 1990, 265:10049-10054
24. 2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 1984, 159:641-646
25. Shiroo M, Kawahara E. Nakanishi I, Migita S: Specific deposition of serum amyloid A protein 2 in the mouse. Scand J Immunol 1987, 26:709-716
26. de Beer MC, de Beer FC, McCubbin WD, Kay CM, Kindy MS: Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993, 268:20606-20612
27. Sipe JD, Carreras I, Gonnerman WA, Cathcart ES, de Beer MC, de Beer FC: Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol 1993, 143:1480-1485
28. Sipe JD, McAdam KPWJ, Uchino F: Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest 1978, 38:110-114
29. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M: Further characterization of amyloid-enhancing factor. Lab Invest 1982, 47: 139-146
30. Shirahama T, Miura K, Ju ST, Kisilevsky R, Gruys E, Cohen AS: Amyloid-enhancing factor-loaded macrophages in amyloid formation. Lab Invest 1990, 62:61-68
31. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T, Uchino F: Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch [A] 1989, 415:411-419
32. 2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies. J Pathol (Lond) 1994, 173:127-134
33. 2 in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid Int J Exp Clin Invest 1997, 4:40-48
34. Tagouri YM, Sanders PW, Picken MM, Siegal GP, Kerby JD, Herrera GA: In vitro AL-amyloid formation by rat and human mesangial cells. Lab Invest 1996, 74:290-302
35. Isaac J, Kerby JD, Russell WJ, Dempsey SC, Sanders PW, Herrera GA: In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid Int J Exp Clin Invest 1998, 5:238-246
36. Kluve-Beckerman B, Yamada T, Hardwick J, Liepnieks JJ, Benson MD: Differential plasma clearance of murine acute phase serum amyloid A proteins SAA1 and SAA2. Biochem J 1997, 322:663-669
37. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 1962, 10:355-364
38. Perry SW, Epstein LG, Gelbard HA: In situ trypan blue staining of monolayer cell cultures for permanent fixation and mounting. BioTechniques 1997, 22:1020-1024
39. Schagger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range of 1 to 100 kDa. Anal Biochem 1987, 166:368-379
40. Kluve-Beckerman B, Song M, Benson MD, Liepnieks, JJ: Recombinant murine serum amyloid A from baculovirus-infected insect cells: purification and characterization. Biochim Biophys Acta 1993, 1182: 303-310
41. Yamada T, Liepnieks JJ, Benson MD, Kluve-Beckerman B: Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin. J Immunol 1996, 157:901-907
42. Harper JD, Lansbury PT: Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997, 66:385-407
43. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB: On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 1996, 93:1125-1129
44. Kisilevsky R, Fraser PE: Aβ amyloidogenesis: unique, or variation on a systemic theme? Crit Rev Biochem Mol Biol 1997, 32:361-404
45. Westermark GT, Engstrom U, Westermark P: The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 1992, 182:27-33
46. SAA) donors by murine macrophages of four different mouse strains. Virchows Arch 1998, 432:547-555
47. Kisilevsky R, Subrahmanyan L: Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992, 66:778-785
48. Shirahama TS, Cohen AS: Intralysosomal formation of amyloid fibrils. Am J Pathol 1975, 81:101-116
49. Jarrett JT, Berger EP, Lansbury PT: The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697
50. Naiki H, Nakakuki K: First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro. Lab Invest 1996, 74:374-383
51. Niewold TA, Gruys E, Kisilevsky R, Shirahama TS: Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis. Scand J Immunol 1991, 34:101-107
52. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P: Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998, 95:2558-2563
53. Kisilevsky R, Gruys E, Shirahama T: Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid Int J Exp Clin Invest 1995, 2:128-134
54. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD: In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand J Immunol 1995, 41:570-574
55. Patel H, Bramall J, Waters H, de Beer M, Woo P: Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996, 318:1041-1049